MICHAEL ST AMAND: Open Payments
NPI 1023508751 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 35 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $391 · 2025 $1,034
Food & beverage: $969Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $405 |
| GENZYME CORPORATION | 3 | $220 |
| Janssen Biotech, Inc. | 8 | $175 |
| Lilly USA, LLC | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Organon LLC | 1 | $34 |
| LEO Pharma Inc. | 1 | $29 |
| Amgen Inc. | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $16 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, TALTZ, COSENTYX, VTAMA, ANZUPGO.
Industry payments across OR — which companies pay providers there.
